Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition (Details)

v3.19.1
Revenue Recognition (Details) - USD ($)
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Total revenues $ 2,472,517 $ 1,623,366
Functional Neurology [Member]    
Total revenues 1,604,645 1,161,335
Biologics And Drug Delivery [Member]    
Total revenues 284,910 198,465
Capital Equipment [Member]    
Total revenues 274,399 178,798
Capital Equipment and Other [Member]    
Total revenues 211,202 84,768
Service and Other Revenues [Member]    
Total revenues 308,564 84,768
Product Revenues [Member]    
Total revenues 2,163,953 1,538,598
Biologics And Drug Delivery [Member]    
Total revenues $ 97,362